Overview

Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
To further characterize the transfer potential of marketed testosterone gel and new 1.62% formulation.
Phase:
Phase 1
Details
Lead Sponsor:
Solvay Pharmaceuticals
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate